Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models

Fig. 1

Posterior distributions of initial efficacy against infection for 5–17 month and EPI cohort for best fitted model. Posterior distributions of efficacy against infection for the 5–17 month cohort and EPI cohort for models fitted with the adjusted transmission assumptions (ii). Results are from final model fit, fitting vaccine properties initial efficacy, half-life against infection for exponential decay, site-specific access to effective treatment, and site-specific variation in incidence. The distribution is shown for efficacy when fitting for both cohorts; rose colour indicates the 5–17 month cohort and blue the EPI cohort

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us